{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T10:53:01Z","timestamp":1772794381351,"version":"3.50.1"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CMAR"],"DOI":"10.2147\/cmar.s68373","type":"journal-article","created":{"date-parts":[[2015,8,20]],"date-time":"2015-08-20T01:39:04Z","timestamp":1440034744000},"page":"265","source":"Crossref","is-referenced-by-count":9,"title":["The treatment landscape in thyroid cancer: a focus on cabozantinib"],"prefix":"10.2147","author":[{"given":"Maria","family":"Cabanillas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Weitzman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2015,8]]},"container-title":["Cancer Management and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=26601","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T22:48:56Z","timestamp":1477867736000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/the-treatment-landscape-in-thyroid-cancer-a-focus-on-cabozantinib-peer-reviewed-article-CMAR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/cmar.s68373","relation":{},"ISSN":["1179-1322"],"issn-type":[{"value":"1179-1322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8]]}}}